NCT00030108View on ClinicalTrials.gov

Ixabepilone in Treating Young Patients With Solid Tumors or Leukemia That Haven't Responded to Therapy

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

November 30, 2001

Primary Completion Date

March 31, 2010

Study Completion Date

April 30, 2010

Conditions
Brain and Central Nervous System TumorsChildhood Germ Cell TumorExtragonadal Germ Cell TumorKidney CancerLeukemiaLiver CancerNeuroblastomaOvarian CancerSarcomaUnspecified Childhood Solid Tumor, Protocol Specific
Interventions
DRUG

ixabepilone

Trial Locations (2)

20010-2970

Children's National Medical Center, Washington D.C.

20892-1182

Warren Grant Magnuson Clinical Center - NCI Clinical Trials Referral Office, Bethesda

All Listed Sponsors
lead

National Institutes of Health Clinical Center (CC)

NIH

collaborator

National Cancer Institute (NCI)

NIH

NCT00030108 - Ixabepilone in Treating Young Patients With Solid Tumors or Leukemia That Haven't Responded to Therapy | Biotech Hunter | Biotech Hunter